SynthesisArchives of dermatological research2024

The efficacy and safety of relatlimab/nivolumab combination therapy in patients with advanced melanoma: a systematic review.

Saba Hasanzadeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.